scout
Opinion|Videos|December 3, 2024

R/R MM Treatment Landscape: Role of Bispecifics

Dr Nadeem discusses his case details and shares his initial thoughts. He then reviews the current treatment landscape for relapsed/refractory multiple myeloma, including his experience with bispecifics in practice and his challenges in using them.

Episodes in this series

Video content above is prompted by the following

Briefly discuss your case details and share your initial thoughts.

  • Can you briefly review the current treatment landscape for patients with relapsed/refractory multiple myeloma?
  • What has been your experience with using bispecifics in practice?
  • What are the challenges you are seeing?

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!

Related Content